4/A//SEC Filing
Floyd Robert Michael 4/A
Accession 0001567619-22-000773
CIK 0001533743other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:24 PM ET
Size
5.9 KB
Accession
0001567619-22-000773
Insider Transaction Report
Form 4/AAmended
Floyd Robert Michael
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2021-12-31+6,722→ 22,780 totalExercise: $0.00→ Common Stock (6,722 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
- [F2]This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001828217
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:24 PM ET
- Size
- 5.9 KB